Comparative efficacy of corticosteroid injection, extracorporeal shock wave therapy, and radiofrequency ablation for chronic plantar fasciitis: a prospective randomized controlled trial

皮质类固醇注射、体外冲击波疗法和射频消融治疗慢性足底筋膜炎的疗效比较:一项前瞻性随机对照试验

阅读:2

Abstract

BACKGROUND: Chronic plantar fasciitis is a common cause of persistent heel pain, often resistant to conservative treatments. This prospective, randomized controlled trial (ClinicalTrials.gov: NCT06737445) aimed to compare the effectiveness of corticosteroid injection (CSI), extracorporeal shock wave therapy (ESWT), and radiofrequency thermal lesioning (RTL) in managing chronic plantar fasciitis. METHODS: Patients with chronic plantar fasciitis, unresponsive to 6 months of conservative treatment, were included. They were divided into three groups: CSI, ESWT, and RTL. Corticosteroid injections were given under ultrasound guidance, ESWT was applied weekly for three weeks, and RTL was a single-session procedure. The primary outcome was change in Visual Analog Scale (VAS) for pain. Secondary outcomes included the Foot Function Index (FFI) and Roles and Maudsley score, assessed at baseline, 1, 6, and 12 months post-treatment. RESULTS: The CSI group included 20 feet from 18 patients, the ESWT group had 19 feet from 15 patients, and the RTL group included 23 feet from 16 patients. At 12 months, the RTL group showed significantly better outcomes in the Roles and Maudsley Score compared to ESWT and CSI, with no significant differences at 1 and 6 months. In FFI, the RTL group had significantly better scores than ESWT at 6 and 12 months. For VAS scores, the CSI group had better outcomes than ESWT at 1 month, but by 6 and 12 months, RTL demonstrated superior pain relief compared to both CSI and ESWT. CONCLUSION: RTL proved to be the most effective treatment for chronic plantar fasciitis, showing superior results, particularly at 12 months, in the Roles and Maudsley Score, Foot Function Index, and VAS scores compared to ESWT and CSI. LEVEL OF EVIDENCE: Level 1, prospective randomized controlled study. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-026-09542-1.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。